Skip to Content

Soolantra Approval History

FDA Approved: Yes (First approved December 19, 2014)
Brand name: Soolantra
Generic name: ivermectin
Dosage form: Cream
Company: Galderma Laboratories, L.P.
Treatment for: Rosacea

Soolantra (ivermectin) is a topical antiparasitic with anti-inflammatory properties for the treatment of rosacea potentially caused by the microscopic skin mite Demodex folliculorum.

Development History and FDA Approval Process for Soolantra

DateArticle
Dec 23, 2014Approval Galderma Receives FDA Approval of Soolantra (ivermectin) Cream for Rosacea

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide